|
| 37531326 | Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references. | | 2023 |
| 36171104 | Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network. | Journal of Neurology, Neurosurgery and Psychiatry | 2023 |
| 36418785 | Excess costs of multiple sclerosis: a register-based study in Sweden. | | 2023 |
| 37558400 | Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy. | | 2023 |
| 37329786 | Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries. | | 2023 |
| 36816812 | Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers. | | 2023 |
| 37392018 | Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis. | | 2023 |
| 37192793 | Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. | | 2023 |
| 36629499 | Association between exposure to combustion-related air pollution and multiple sclerosis risk. | | 2023 |
| 37001984 | Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression. | | 2023 |
| 36692896 | Observed associations between indicators of socioeconomic status and risk of multiple sclerosis in Sweden are explained by a few lifestyle-related factors. | | 2023 |
| 37435869 | The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study. | | 2023 |
| 36929246 | Self-reported restrictions in different life domains and associated factors among people with multiple sclerosis in Sweden. | | 2023 |
| 36539267 | Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study. | | 2023 |
| 36603296 | Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort. | | 2023 |
| 36529068 | Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden. | | 2023 |
| 34612098 | Trajectories of sickness absence and disability pension days among people with multiple sclerosis by type of occupation. | Multiple Sclerosis Journal | 2022 |
| 35496757 | Comparison of employment among people with Multiple Sclerosis across Europe. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2022 |
| 35496759 | Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2022 |
| 35560551 | Copy number variations across the blood-brain barrier in multiple sclerosis. | Annals of Clinical and Translational Neurology | 2022 |
| 35993445 | COVID-19 clinical outcomes and DMT of MS patients and population-based controls. | Annals of Clinical and Translational Neurology | 2022 |
| 35476434 | Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis. | Sci Adv | 2022 |
| 35917745 | Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. | Mult Scler Relat Disord | 2022 |
| 35781876 | Self-employment, sickness absence, and disability pension in multiple sclerosis. | Acta Neurologica Scandinavica | 2022 |
| 35470158 | Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. | Ann Rheum Dis | 2022 |
| 36570871 | Association between brain volume and disability over time in multiple sclerosis. | | 2022 |
| 34080926 | A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry. | Multiple Sclerosis Journal | 2022 |
| 34124961 | High antibody levels against human herpesvirus-6A interact with lifestyle factors in multiple sclerosis development. | Multiple Sclerosis Journal | 2022 |
| 34212816 | Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry. | Multiple Sclerosis Journal | 2022 |
| 34984719 | Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse. | Annals of Neurology | 2022 |
| 35309300 | Smoking Attributable Risk in Multiple Sclerosis. | Frontiers in Immunology | 2022 |
| 35069404 | Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function. | Frontiers in Neurology | 2021 |
| 33970446 | Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group. | PharmacoEconomics | 2021 |
| 33753006 | Bariatric and metabolic surgery in patients with morbid obesity and multiple sclerosis - a nationwide, matched cohort study. | | 2021 |
| 33487091 | A multiple sclerosis disease progression measure based on cumulative disability. | Multiple Sclerosis Journal | 2021 |
| 34294805 | Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study. | Scientific Reports | 2021 |
| 33748960 | Socioeconomic consequences of multiple sclerosis-A systematic literature review. | Acta Neurologica Scandinavica | 2021 |
| 33687974 | DRB1-environment interactions in multiple sclerosis etiology: results from two Swedish case-control studies. | Journal of Neurology, Neurosurgery and Psychiatry | 2021 |
| 33900144 | Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network. | Multiple Sclerosis Journal | 2021 |
| 34002096 | Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. | Nat Genet | 2021 |
| 33465039 | Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology. | Neurology: Neuroimmunology and NeuroInflammation | 2021 |
| 33616605 | Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis. | JAMA Neurology | 2021 |
| 33986119 | Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis. | Journal of Neurology, Neurosurgery and Psychiatry | 2021 |
| 33605804 | Depression and multiple sclerosis: A bidirectional Mendelian randomisation study. | Multiple Sclerosis Journal | 2021 |
| 33871105 | Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity. | J Intern Med | 2021 |
| 34357597 | Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County. | Acta Neurologica Scandinavica | 2021 |
| 33815259 | Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network. | Frontiers in Neurology | 2021 |
| 33263261 | Accurate classification of secondary progression in multiple sclerosis using a decision tree. | Multiple Sclerosis Journal | 2021 |
| 33429303 | Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden. | Multiple Sclerosis and Related Disorders | 2021 |
| 34398221 | Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies. | JAMA Neurology | 2021 |